Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Barten

Showing results (91-100 of 98) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 98 results.
Bioorganic & Medicinal Chemistry Letters|July 4, 2007
N-(5-chloro-2-(hydroxymethyl)-N-alkyl-arylsulfonamides as gamma-secretase inhibitorsMichael F Parker, Donna M Barten, Carl P Bergstrom, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 24, 2008
P-glycoprotein efflux and other factors limit brain amyloid beta reduction by beta-site amyloid precursor protein-cleaving enzyme 1 inhibitors in miceJere E Meredith, Lorin A Thompson, Jeremy H Toyn, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery and Evaluation of BMS-708163, a Potent, Selective and Orally Bioavailable γ-Secretase InhibitorKevin W Gillman, John E Starrett, Michael F Parker, et al.
Bioorganic & Medicinal Chemistry Letters|November 17, 2010
Synthesis and SAR of indole-and 7-azaindole-1,3-dicarboxamide hydroxyethylamine inhibitors of BACE-1Lawrence R Marcin, Mendi A Higgins, F Christopher Zusi, et al.
Bioorganic & Medicinal Chemistry Letters|October 7, 2011
Synthesis and in vivo evaluation of cyclic diaminopropane BACE-1 inhibitorsLorin A Thompson, Jianliang Shi, Carl P Decicco, et al.
Kidney International|January 23, 2025
KDIGO 2025 clinical practice guideline for the evaluation, management, and treatment of autosomal dominant polycystic kidney disease (ADPKD): executive summaryVicente E Torres, Curie Ahn, Thijs R M Barten, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 1, 2013
Pharmacodynamics of selective inhibition of γ-secretase by avagacestatCharles F Albright, Randy C Dockens, Jere E Meredith, et al.
The Journal of Biological Chemistry|June 25, 2008
The amyloid-beta rise and gamma-secretase inhibitor potency depend on the level of substrate expressionCatherine R Burton, Jere E Meredith, Donna M Barten, et al.
Pageof 10

Showing results (91-100 of 98) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 98 results.
Bioorganic & Medicinal Chemistry Letters|July 4, 2007
N-(5-chloro-2-(hydroxymethyl)-N-alkyl-arylsulfonamides as gamma-secretase inhibitorsMichael F Parker, Donna M Barten, Carl P Bergstrom, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 24, 2008
P-glycoprotein efflux and other factors limit brain amyloid beta reduction by beta-site amyloid precursor protein-cleaving enzyme 1 inhibitors in miceJere E Meredith, Lorin A Thompson, Jeremy H Toyn, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery and Evaluation of BMS-708163, a Potent, Selective and Orally Bioavailable γ-Secretase InhibitorKevin W Gillman, John E Starrett, Michael F Parker, et al.
Bioorganic & Medicinal Chemistry Letters|November 17, 2010
Synthesis and SAR of indole-and 7-azaindole-1,3-dicarboxamide hydroxyethylamine inhibitors of BACE-1Lawrence R Marcin, Mendi A Higgins, F Christopher Zusi, et al.
Bioorganic & Medicinal Chemistry Letters|October 7, 2011
Synthesis and in vivo evaluation of cyclic diaminopropane BACE-1 inhibitorsLorin A Thompson, Jianliang Shi, Carl P Decicco, et al.
Kidney International|January 23, 2025
KDIGO 2025 clinical practice guideline for the evaluation, management, and treatment of autosomal dominant polycystic kidney disease (ADPKD): executive summaryVicente E Torres, Curie Ahn, Thijs R M Barten, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 1, 2013
Pharmacodynamics of selective inhibition of γ-secretase by avagacestatCharles F Albright, Randy C Dockens, Jere E Meredith, et al.
The Journal of Biological Chemistry|June 25, 2008
The amyloid-beta rise and gamma-secretase inhibitor potency depend on the level of substrate expressionCatherine R Burton, Jere E Meredith, Donna M Barten, et al.
Pageof 10